Marty Makary nominated by Trump to lead FDA amid mixed reactions on health views

Marty Makary, a surgeon and researcher at Johns Hopkins, has been nominated by President-elect Donald Trump to lead the U.S. Food and Drug Administration. His selection has drawn mixed reactions, with some praising his qualifications and others expressing concern over his views on vaccines and health policy. Makary has been critical of pandemic measures and the FDA's response to COVID-19. He has also aligned himself with Robert F. Kennedy Jr., known for his anti-vaccine stance, which has raised alarms among some health experts regarding his potential leadership at the FDA. Trump stated that Makary will aim to improve the FDA's efficiency and scientific standards. His nomination requires confirmation from the Republican-led Senate, and analysts suggest his approach may differ from current FDA practices, potentially impacting drug approval processes.